CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- DEFA14A Proxy Proxy Materials
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- DEFA14A Proxy Proxy Materials
- 8-K Event Delisting notice
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- 8-K Event Delisting notice
- PREM14A Deal PREM14A
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement
- 10-K Report Annual Report
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Acquisition or sale completed · Other events
- SC 13G/A Stake Amended Statement of Ownership
Page 15 of 81 · 1,604 filings